Kiora Pharmaceuticals(KPRX) - 2023 Q4 - Annual Results

WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 25, 2024 KIORA PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Delaware UNITED STATES SECURITIES AND EXCHANGE COMMISSION (State or other jurisdiction of incorporation) 001-36672 98-0443284 (Commission File Number) (IRS Employer Identification No.) 332 Encinitas Blvd. Suite 102 Encinitas, CA 92024 (858) 224-960 ...